calls for a better implementation of the existing regulation in regards to the market authorization for low-risk PPPs;
poziva k boljšemu izvajanju veljavne uredbe v zvezi z dovoljenji za promet s fitofarmacevtskimi sredstvi z majhnim tveganjem;